跳至主要内容
临床试验/ISRCTN61649292
ISRCTN61649292已完成4 期

A randomised, double-blind, placebo-controlled trial to investigate the effect of intensified treatment with high dose rifampicin and levofloxacin for adult patients with tuberculous meningitis

niversity of Oxford (UK)0 个研究点目标入组 817 人开始时间: 2009年10月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
817

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Greater or equal to 15 years of age (either sex) with a clinical diagnosis of tuberculous meningitis

排除标准

  • 1. Positive cerebrospinal fluid (CSF) Gram or India Ink stain
  • 2. Known or suspected pregnancy
  • 3. Known hypersensitivity/intolerance to fluoroquinolones or rifampicin
  • 4. Estimated glomerular filtration rate (GFR) less than 40 ml/min
  • 5. Laboratory contraindications to antituberculous therapy:
  • 5.1. Bilirubin greater than 2.5 x upper limit of normal (ULN)
  • 5.2. Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) greater than 5 x ULN
  • 6. Lack of consent

研究者

发起方
niversity of Oxford (UK)

相似试验